91影库

Interview

Meet Ann West, leader of the PAAC

Sarina Neote
Nov. 15, 2023

Ann West is a professor of chemistry and biochemistry and the associate vice president for research and partnerships at the University of Oklahoma.

She’s also the new chair of the 91影库 and Molecular Biology’s Public Affairs Advisory Committee.

Ann West
Ann West

91影库Today talked to West about her advocacy experience and reasons for getting involved as she embarks on her two-year term.

The interview has been condensed and edited for style and clarity.

What do you think is important for 91影库members to know about the PAAC?

First, I think that we work very hard in representing the ASBMB.

We have a fantastic 18-member group, some of whom have been recently recruited. We discuss a lot of broad topics, we hear different opinions, and we often can come to a consensus statement that we think best represents the interests of the society. That’s not always an easy thing to do.

I hope that everyone on the PAAC feels like they have a forum for expressing views and for contributing to our public-facing documents, whether it’s a response to an agency call for information or interacting with various funding agencies on issues where we’re able to contribute.

I really hope that our members feel they have a voice and can express their opinions.

Why do you think it’s important for scientists to advocate?

Advocating is so much more important since COVID-19, honestly, because the amount of misinformation and disinformation that we all encountered was really concerning. I think that we owe it to society — in light of the federal funding that we receive — to do our best to communicate that science should be trusted. That’s an important aspect of being on the PAAC: trying to communicate with not just the membership but with the general public.

Did you have any experience with advocating before joining the PAAC?

I was a complete rookie. It was not something that was at the forefront of my mind. However, I am fairly service-minded and want to give back to both my profession and a great society like the ASBMB. So, no, I had no experience to lean on. But once I knew more, then I became interested.

What scared you about policy and advocacy?

I think, inherently, I have an introverted personality. And I was worried it was going to be too public-facing. But, you know, it really has not turned out to be what I feared.

I came to politics, in general, I would say late in life, in part because I didn't become a naturalized citizen until about five years ago. I tended to avoid political discussions or arguments. I didn’t necessarily follow a lot of what was going on in Washington, D.C. I felt like I didn't have that experience or understanding of all the things that go on in our nation's capital.

Now, of course, being a faculty member depends on federal research funding. I did want to know how our lawmakers are involved in making decisions, especially at appropriations time when budgets are being considered. And I was interested in how our federal granting agencies both received funding and allocated funding within agencies such as the National Institutes of Health and the National Science Foundation.

I became more and more and more interested, as a faculty member, because it’s part of our livelihood.

Courtesy of Ann West
Ann West and PAAC member Mary Lipton visit congressional offices during the ASBMB’s 2023 Hill Day.

How was your first in-person Capitol Hill Day in May?

I loved the experience. I loved the vibrancy of being in the Capitol Hill area and the bustling hallways of the congressional offices. Growing up in the Northeast, I’d been to Washington, D.C., a number of times but never in the halls of Congress. It was really kind of a thrill.

I was really impressed by the receptiveness of the congressional leaders we met with. I’m not sure that all of our messages were heard, but at least we were able to have a voice. And that was very rewarding.

Any final thoughts to share?

I realized, through the years, that we’re not always training the students in our laboratory to go on to do the same thing that we do. It’s been really great and refreshing to see what the younger generation is looking toward — with a science background but putting it to a different use in the area of science advocacy. If that’s what you're interested in, you should definitely pursue it.

Also, you don't have to make the decision to be an advocate at age 20. You can decide like me, a little bit older, that this is something that I can engage in and give back to a science community that nurtured my career — and hopefully be effective.

“I think that we owe it to society — in light of the federal funding that we receive — to do our best to communicate that science should be trusted.” — Ann West

Enjoy reading 91影库Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Sarina Neote

Sarina Neote is ASBMB's director of public affairs.

Get the latest from 91影库Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

From dust to discovery
Profile

From dust to discovery

July 23, 2025

From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women鈥檚 health.

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

91影库members recognized as Allen investigators
Member News

91影库members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, 91影库educators say
Advice

AI can be an asset, 91影库educators say

July 9, 2025

Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.